Venetoclax in addition to ibrutinib effective as a treatment for chronic lymphocytic leukemia
Bookmark1. High genetic risk participants with chronic lymphocytic leukemia (CLL) taking venetoclax in addition to ibrutinib achieved high rates of achievement of undetectable measurable dis...